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Abstract
Background: The aim was to use the existing surveillance data sources of cancer in Morocco that could be used to
better describe cancer mortality and incidence trends in Morocco.
Methods: National incidence data were derived from population-based cancer registries. Mortality data were
collected from the international GLOBOCAN database.
Results: An overview of the main results was presented. In general, the most commonly diagnosed cancers in men
are lung and prostates whereas in women, breast and cervical cancers are the pre-dominant cancers. Fifty nine percent
and of breast and 65.7 % of cervical cancers in women are diagnosed at stages II and III. Cancer remains the second
highest cause of mortality in Morocco.
Conclusion: The data provides a description of the cancer incidence and trends in the Moroccan population. The
Moroccan national cancer program should aim for more coherent, consistent and comparable incidence data between
different cancer registries in the country, and develop uniform datasets with respect to quality.
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Résumé
Introduction: L'objectif était d'utiliser les sources de données existantes de surveillance du cancer qui pourraient
être utiles pour décrire les tendances d’incidence et de mortalité du cancer au Maroc.
Méthodes: Les données de morbidité et mortalité nationales et internationales disponibles ont été explorées. Les
registres populationnels de cancer couvrent les données d'incidence régionale. Les données de mortalité sont
disponibles par les données internationales de Globocan.
Résultats: Un aperçu des principaux résultats a été présenté. Globalement, les cancers les plus fréquents sont le
poumon et la prostate chez les hommes; le sein et le col utérin chez les femmes; ces deux cancers représentant
56,3 % de cancers féminins. Les cancers de sein et du col sont diagnostiqués dans 59 % et 65,7 % aux stades II et
III. Le cancer est la deuxième cause de mortalité au Maroc.
Conclusion: Les données fournissent une description de l'incidence des cancers et leurs tendances dans la
population marocaine. Le programme national du cancer marocaine devrait viser pour les données d'incidence
cohérents et comparables entre les différents registres du cancer dans le pays, et de développer des ensembles
de données uniformes par rapport à la qualité.
Mots-clès: Registre des cancers, Incidence, Mortalité, Morbidité, Maroc
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Background
Cancer is increasingly growing as a major health problem
in both developed and developing countries amongst the
chronic diseases [1]. Cancer imposes a heavy economic,
health, and social burden. It is a global pandemic affecting
both developed and developing regions, but the cancer toll
is rapidly increasing in low and middle-income countries,
where resources for prevention, diagnosis and treatment
are limited or nonexistent [2]. Worldwide, cancer inci-
dence could potentially increase to as many as 17 million
new cases per year by 2020. Of these, it is estimated that
as many as 1.5 million cases will occur alone in Africa [3].
The professional oncology community is being in-
creasingly called upon to define pragmatic and realistic
approaches in order to provide decision makers with
the evidence that cancer is increasingly growing a major
public health problem and provide information that can
be used to monitor its public health threats to general
population [4].
Hospital registries and surveillance systems that collect
information on new cases, trends, diagnosis, treatment
and mortality due to cancer in a systematic and reliable
manner are key to build cancer prevention and control
programme.
Data from cancer registries provide a description of
the disease burden by population and over time, but
geographic heterogeneities also need to be understood
to develop and improve rational cancer control policies.
The Middle East Africa (MEA) countries have their own
patterns [5], and Morocco is among the countries that
have a particular demographic and epidemiological situ-
ation. The estimated population of Morocco is around
32.6 million people, with a life expectancy at birth of
74.8 years [6]. 6.8 % of subjects are estimated to be over
65 and 29 % of the population is under 15 years old. The
young population in Morocco is associated with a high
fertility rate of approximately 2.59 births per woman dur-
ing the period 2006–2011 [7]. In March 2010, Morocco
officially launched the National Plan of Cancer Control,
aiming at reducing morbidity and mortality rates and
improving survival and quality of life of cancer patients
by promoting prevention, early detection and effective
screening practice; by improving diagnosis, treatment,
and palliative care services; and by supporting the de-
velopment of facilities and research for cancer through-
out the country [8].
The aim of the current study was to use the existing
surveillance data sources of cancer to describe cancer
mortality and incidence trends in Morocco and provide
an overview of cancer profile in Morocco.
Methods
Morbidity and mortality statistics on cancer were obtained
from national and internationaldata sources: whereas
national data on cancer were mainly provided by the
Moroccan cancer registries, international estimates are
mainly based on data available from the IARC.
National morbidity data sources
The main sources of cancer morbidity data are population-
based cancer registries. In Morocco, two population-based
registries are the principal sources of reliable cancer mor-
bidity data. The first one is region-based and concerns
the administrative region of Casablanca (Region du
Grand Casablanca). This registry covers around 12 % of
the Moroccan population and is usually tied to state
health departments of the region. The data are col-
lected retrospectively on cancer patient from private
and public care structures in the Casablanca region,
such as hospital departments, private hospitals and
pathological laboratories [9]. This data collection is
made by medical doctors who are well trained on can-
cer registration and who are also involved in the man-
agement of database after the collection. The first
report of this registry published cancer data from 2004
[10] and a more recent publication has covered the
period from 2005–2007 [11].
The second one, the population-based cancer regis-
try of Rabat, covering around 2.1 % of the Moroccan
populationand this registry reports all new cancer
casesfrom 2005 onwards among residents in Rabat
[12]. This registry usesan active method of data col-
lection consistingofgathering data relative to any new
diagnosed cancer including visits by registry staff to
all data sources, essentially hospitals, pathological la-
boratories, and private clinics in Rabat [12]. Themost
recent report of this registry published data for the
period from 2006–2008 [13].
Data from these two population-based registries al-
lows to estimatethe global and national incidence can-
cer rate and the incidence rates by localization. To
compare data at national or international level, these
registries estimate a standardized incidence by using
the Moroccan population and the world populationas
references [9, 12]. Data collected by these cancer regis-
tries usually include date of diagnosis, confirmation of
diagnosis, histological type and differentiation, exten-
sion of the tumor, classification, stage and treatment, as
well as socio-demographic information. Another regis-
try of the oncology hospital hasbeen developed in the
region of Marrakech, but the results have not been
published yet. In theFez region, a cancer registry of
Hassan II Hospitalis currently being developed to col-
lect data and to evaluate patient care in this north
centre region of Morocco. They can also be used in
studies that compare patterns of care among providers
or geographic regions [14].
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National mortality data sources
The main sources are data published annually by the
Ministry of Health [7]. The information is obtained from
death certificates completed by medical health workers
of the Municipal Hygiene Office throughout the country
since 1950. Currently, no data related to the cause of
death according to International Classification of Dis-
eases (ICD)10 is available in the conventional system of
surveillance.
International morbidity and mortality data sources
We used the CancerMondialwebsite to get access to
various databases containing information on the occur-
rence of cancer worldwide held and managed by the
Section of Cancer Information of IARC. Two of the
principal cancer databases available on this website are
GLOBOCAN, which provides the most recent estimates
for 2012’s cancer incidence, mortality rate,and preva-
lence for 28types of cancer in 184 countries [2], and
Cancer Incidence in Five Continents (CI5), which pro-
vides access to detailed information on the incidence of
cancer recorded by cancer registries (regional or na-
tional) worldwide [15]. For Morocco, as for other coun-
tries, data on cancer incidence and mortality are available
on the GLOBOCAN. These data are collected by IARC
[2]. The datais based on provisional estimates of cancer
andspecific mortality in every country, and it allows mak-
ing predictions of mortality and morbidity until the year
2035. The cancer data concerning incidence, morbidity
and population survival analysis based onthe Casablanca
cancer registry are not yet available on the CI5 database.
Results
Main morbidity and mortality data
Between 2005 and 2007, the Casablanca cancer population-
based registry recorded 11,923 cases (all cancer localiza-
tions), of which 5,551 cases (46.6 %) were recorded in males
[9]. The incidence rates (CR: Crude rate, ASR (M): Age
Standardized Rate in Morocco, ASR (W): Age Standardized
Rate in the World) of global cancers are displayed in
Table 1. All rates tended to increase in both men and
women;the ASR (W) passed from 100.3/100000 in 2004 to
138.5/100000 in 2008 (Table 1).
The four most common cancers sites among males were
lung (ASR = 25.9 per 100000), prostate (15.6), bladder
(10.2) and colon-rectum (8.4) (proportions of Casablanca
cancer registry: 22.1 %, 10.5 %, 7.0 % and 7.2 % of all can-
cers respectively (Fig. 1, Table 2), whereas in females, the
top four cancers sites were breast (ASR = 38.6), cervical
(14.6), thyroid (7.1) and colon-rectum (6.0) (proportions
of Casablanca cancer registry: 34.3 %, 13.3 %, 6.5 % and
5.0 % of all cancers respectively (Fig. 2, Table 2). The Rabat
cancer registry revealed the same pattern with regards to
cancer localizations (Figs. 1 and 2).
As shown in Table 3, the mean of age was 49.5 years
for breast cancer and 52.9 years for cervical cancer. In
men, it was 59.5 years for lung cancer and 70.4 years for
prostate cancer. For both sexes, the median age was
around 57 years for colon cancer. Breast and cervical
cancers are diagnosed at stages II (59.0 %) and III
(65.7 %) in women, and only 4.6 % of lung cancers are
diagnosed at stages I and II in men (Table 3).
According to the Ministry of Health sources, cancer is
only second to cardiovascular diseases as the leading
cause of death in Morocco since 2004 [16] with a mor-
tality rate of 8.3 %. Cancer remained the second cause of
mortality through 2011 as well (11.5 %) [7].
According to GLOBOCAN 2012, 14.1 million new
cancer cases and 8.2 million cancer deaths occurred in
2012, compared to 12.7 million and 7.6 million respect-
ively in 2008 [2].
Lung (1.8 million cases, which is 13.0 % of the total),
breast (1.7 million cases, or 11.9 % of the total) and the
colorectal cancer (1.4 million cases, or 9.7 % of the
total) were the most commonly diagnosed cancers. The
most frequent causes of death from cancer were lung
Table 1 Cancer incidence, per 100 000 inhabitants, in Morocco according to gender and years (2004–2008: data from Casablanca
and Rabat cancer registries) [9, 12]
2004 2005 2006 2007 2008
Registry Men Women Men Women Men Women Men Women Men Women
Casablanca Case 1503 1833 1680 1994 1788 2091 2083 2287 - -
CR 84.0 100.0 93.1 107.4 97.8 111.0 112.4 119.8 - -
ASR (M) - - 88.8 95.1 94.0 99.7 106.6 107.5 - -
ASR (W) 100.3 104.2 112.2 110.6 117.1 115.1 132.8 121.9 - -
Rabat Cases - - 384 379 401 394 410 434 430 404
CR - - 125.5 115.9 130.5 119.5 132.6 130.4 138.3 120.5
ASR (M) - - 104.8 96.0 107.6 97.2 110.2 106.3 114.6 97.7
ASR (W) - - 132.9 112.2 134.9 112.1 137.0 120.7 138.5 110.9
CR Crude rate, ASR (M) Age Standardized Rate (incidence standardized on Morocco population), ASR (W) Age Standardized Rate (incidence standardized on
World population)
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(1.6 million deaths, 19.4 % of the total), liver (0.8 million
deaths, 9.1 % of the total) and stomach (0.7 million deaths,
8.8 % of the total) cancers [2].
Predictive cancer data of Morocco
The projections based on the GLOBOCAN 2012 estima-
tions show a substantial increase of 19.3 million new in-
cidence of cancer each year by 2025 because of the
demographic growth and the ageing of the world popu-
lation [2]. For Morocco, GLOBOCAN 2012 estimated
35,018 new cancer incidence, (16,829 new incidence in
males and 18,189 in females) and 22,798 cancer-related
deaths (12,462 in males and 10,336 in females) (Tables 4
and 5). GLOBOCAN 2012 online analysis [2], estimated
about 20,715 and 16,942 cancer-related deaths, respect-
ively, in male and female by 2030 (Table 5). This
provisional data represents an increases of up of 60 %
from 2012 (assuming no change in risk from 2012).
Discussion
The surveillance data for cancer were collected from can-
cer registries. In general, the information was regularly
and carefully scrutinized [9, 12]. The incidence rates re-
ported by both population-based cancer registries were
considered more accurate than those made by GLOBO-
CAN. In practice, GLOBOCANestimates sex- and age-
Table 2 Cancer incidence, per 100 000 inhabitants,of the most commonly found cancers in Moroccan population according to
gender and years, (2004–2007: data from Casablanca cancer registry) [9]
Women Men
2004 2005 2006 2007 2004 2005 2006 2007
Breast Lung
Case 662 666 690 763 Case 357 373 380 389
ASR (M) 35.0 35.1 35.4 38.6 ASR (M) 25.5 26.0 25.9 25.9
Cervix Prostate
Case 235 272 276 268 Case 124 169 172 207
AS (M) 13.5 15.5 14.9 14.6 ASR (M) 9.6 12.7 12.3 15.6
Thyroid Bladder
Case 97 128 125 148 Case 84 107 113 148
ASR (M) 4.8 6.5 6.5 7.1 ASR (M) 5.8 8.0 7.9 10.2
Colorectal Colorectal
Case 93 96 100 110 Case 102 106 137 134
ASR (M) 5.8 5.6 5.9 6.0 AS (M) 6.5 6.9 9.2 8.4
ASR (M) Age Standardized Rate (Standardized incidence on Morocco population)
Fig. 1 Proportion of cancer cases recorded in men, taken from Casablanca (2005-2007) and Rabat (2006-2008) population- based cancer
registries [9, 12]
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specific incidence rates of cancer in Morocco as the
weighted average of the local rates of 16 countries [2].
In Morocco, no valid data of mortality due to cancer is
currently available. The interpretations and accuracy of
cancer mortality patterns presented in this review could
be affected by incomplete information on routine med-
ical records and death certificates and inaccurate popu-
lation estimates. National studies are in progress to
collect mortality data in Morocco, but they are not pub-
lished yet. Only a national study which aimed to provide
first data on smoking attributable mortality in Morocco
was published in 2014 [17].
Unlike western countries, most Asian and African coun-
tries (including Morocco) do not rely on comprehensive
death registration systems. Instead mortality data are col-
lected and made available through the GLOBOCAN data-
base by the IARC, which provides data from national
incidence estimates using modeled survival for instance,
the estimations for Morocco are from national incidence
estimates of 82 countries [2]. Major advantages in using
this method include national coverage and long-term
availability.
The Moroccan population-based cancer registries pro-
vide main surveillance data of cancer which have an im-
portant roleto ensure reliable and valid information for
decision makersin prevention and control strategies. The
existing cancer registries in Morocco cover less than
15 % of the Moroccan population, thus still there is a
limitation on cancer data obtained from the present
registries and the need for more information on cancer
Fig. 2 Proportion of cancer cases recorded in women, taken from Casablanca (2005-2007) and Rabat (2006-2008) population-based cancer
registries [9, 12]
Table 3 Age and cancer stage distributions of main cancers in
Morocco (2004–2008: data from Casablanca and Rabat cancer
registries) [9, 12]










Breast - 49.5 13.5 44.6 24.4 4.5 13.0
Cervix - 52.9 15.0 38.6 27.1 7.9 11.4
Lung 59.5 - 2.3 2.3 19.1 50.0 26.3
Prostate 70.4 - 0.5 19.8 14.1 17.7 47.9
Colon 56.8 57.2 6.2 22.7 14.8 37.5 18.8
Rectum 58.1 54.2 8.2 16.5 12.3 26.0 37.0
Table 4 Data on cancer rates in Morocco estimated by
Globocan 2012 [2]
Men Women Both sexes
Population (thousands) 15956 16641 32598
Number of new cancer cases (thousands) 16.8 18.2 35.0
ASR (W) 122.7 114.4 117.8
Risk of getting cancer before age 75 (%) 13.6 11.7 12.6
Number of cancer deaths (thousands) 12.5 10.3 22.8
ASR (W) 92.3 66.8 78.4
Risk of dying from cancer before
age 75 (%)
10.2 7.3 8.6
5-year prevalent cases, adult population
(thousands)
30.6 49.0 79.6
Proportion (per 100000) 268.4 398.9 336.0
ASR (W) Age Standardized Rate (Standardized incidence on World population)
Obtel et al. Archives of Public Health  (2015) 73:45 Page 5 of 7
in the other regions covering the remaining 85 % of the
population is apparent.
Nevertheless, for some countries including Morocco,
incomplete coverage of the population yields lowesti-
mated mortality rates whereas for others, the quality of
information for the cause of death is poor.
Despite these limitations, data reported from population-
based cancer registries and GLOBOCAN database contrib-
ute to allow a description of the cancer incidence and
trends in Moroccan population.
Lung cancer is the most common cancer affecting
males, followed by prostate cancer, while breast cancer
represents the most common cancer among females,
followed by cervical cancer. Incidence of bladder and col-
orectalcancer appears to be increasing among Moroccan
population.
In general, more than half of the cancers (56.8 %) and
deaths due to cancer (64.9 %) in 2012 were registered in
the least developed regions in the world, and this trend
is likely to continue by 2025 [2]. The median age of all
cancer types in Morocco was50.5 years for women and
56.6 years for men. Cancer at a young age in Morocco
was more common among women, who represented
67 % of the cases under 50. This was mainly attributable
to the low number of cases recorded among old people
and the young age of the general population [11, 13].
The pattern of cancer risk as seen in the recent study
conducted in North Africa (Morocco, Algeria, Tunisia,
Libya and Egypt) appears quite uncharacteristic [18]. In
every North Africa country, the whole incidence rate
ranges, in both genders, between one third and one half
of what is currently measured in Europe. For the whole
incidence rate, the variations among these countries are
far smaller than the difference between this group of
countries and Europe [19].
In Morocco, breast cancer remains the most common
malignant tumor in females [9, 12]. Stage at diagnosis of
this cancer could be obtained for 82 % cases in 2007. It
was recorded in Casablanca cancer registry as follows:
28 % local, 63 % regional and 9 % distant, in the absence
of screeningprogram [9, 11].
Breast cancer is also the leading cause of death from
cancer in European women. A marked decline in breast
cancer mortality in most European countries in the 1990s
have been attributed to the combined effect of earlier de-
tection and improved treatment mainly in young women.
Soas the population grows older the number of deaths
from breast cancer is still rising (131,000 in 2012 [20] and
131,000 in 2013) [21].
Following this European strategy and in order to re-
spond to preventive objectives of National cancer pro-
gram, Morocco integrated screeningactivities at all levels
of its health care system in several regions in 2011 in an
effort to reduce breast cancer mortality. These screening
programs, focused on the 49–55 years age group,also
strive forthe early detection of cervicalcancer [22]. These
programsfollow the GLOBOCAN 2012 strategy, which
brings to light significant trends of cancer in women and
shows that, at the global level, higher priority must be
given to prevention andtreatment measureson breast
and cervical cancers [2].
WHO has developed guidelines and policies for estab-
lishing effective national cancer control programs ac-
cording to capacity and financial development, in order
to increase cancer control activities [23, 24].
Development of a cancer control program should in-
clude the implementation of cancer registries to assess
the cancer burden, identify priorities and to evaluate the
effectiveness of the cancer program.
Conclusion
The Moroccannational cancer program should aim for
coherent and comparableincidence data between differ-
entcancer registries in the country, and develop uni-
form/homogeneous datasets with respect to quality.
Additionally, population-based cancer registries should
rapidly recordcancer mortality data including causes of
death. It is now important to improve the surveillance of
cancer through the implementation of high-quality can-
cer registries. Thus, the national cancer program should
develop cancer registries in more regions to improve our
knowledge on cancer epidemiology (particularly in rural
areas) and to adapt, if needed, the nationalMoroccan
strategy to better control and cure cancer.
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Table 5 Number of new cases and cancer related deaths of
all cancers excluding non-melanoma skin cancer (all ages)
estimated by predictions analysis of Globocan 2012 [2]
Years Number of new cases Number of cancer-related deaths
Man Woman Both sexes Man Woman Both sexes
2012 16829 18189 35018 12462 10336 22798
2025 23665 24802 48467 17441 14631 32072
2030 27354 27894 55248 20715 16942 37657
2035 30893 30765 61658 23944 19264 43208
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